Skip to content

Author

A. R. Lyon

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Systematic review and network meta-analysis of cardio-protective therapies in cancer patients

Therapies traditionally targeting neurohormonal pathways were most consistently associated with preservation of LVEF, whereas statins and ARNIs showed greater benefit when broader, study-defined cardiotoxicity criteria were applied, whereas ACE inhibitors did not demonstrate consistent benefit.

V. Maharajan, M. Andres, E. Doris et al. · 0 citations
Review Open access Aug 2026

Machine learning—enhanced baseline risk prediction models for cancer therapy related cardiac dysfunction: a systematic review and critical appraisal of methodological quality

Abstract Aims Cancer therapy-related cardiac dysfunction (CTRCD) is a prevalent complication with adverse clinical implications. Guidelines have emphasized the need for reliable baseline risk prediction to guide prevention strategies. While machine learning (ML) has shown promise in cardiovascular medicine, the readine...

M. Andres, Vijay Maharahan, Alexandra Pons Rivarola et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.